Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VTI1A Antikörper (AA 1-175)

VTI1A Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7175463
  • Target Alle VTI1A Antikörper anzeigen
    VTI1A (Vesicle Transport through Interaction with t-SNAREs 1A (VTI1A))
    Bindungsspezifität
    • 9
    • 8
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-175
    Reaktivität
    • 43
    • 26
    • 8
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 41
    • 3
    Kaninchen
    Klonalität
    • 41
    • 3
    Polyklonal
    Konjugat
    • 17
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser VTI1A Antikörper ist unkonjugiert
    Applikation
    • 27
    • 19
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Vesicle transport through interaction with t-SNAREs homolog 1A protein (1-175AA)
    Isotyp
    IgG
    Top Product
    Discover our top product VTI1A Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    VTI1A (Vesicle Transport through Interaction with t-SNAREs 1A (VTI1A))
    Andere Bezeichnung
    VTI1A (VTI1A Produkte)
    Synonyme
    zgc:109895 antikoerper, mvti1 antikoerper, vti1-rp2 antikoerper, DDBDRAFT_0219803 antikoerper, DDBDRAFT_0231536 antikoerper, DDB_0219803 antikoerper, DDB_0231536 antikoerper, MMDS3 antikoerper, MVti1 antikoerper, VTI1RP2 antikoerper, Vti1-rp2 antikoerper, 1110014F16Rik antikoerper, 1110018K19Rik antikoerper, 4921537J05Rik antikoerper, MVti1a antikoerper, Vti1 antikoerper, vesicle transport through interaction with t-SNAREs 1A L homeolog antikoerper, vesicle transport through interaction with t-SNAREs 1A antikoerper, v-SNARE family protein antikoerper, vti1a.L antikoerper, vti1a antikoerper, VTI1A antikoerper, vti1A antikoerper, Vti1a antikoerper
    Hintergrund

    Background: V-SNARE that mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. Involved in vesicular transport from the late endosomes to the trans-Golgi network. Along with VAMP7, involved in an non-conventional RAB1-dependent traffic route to the cell surface used by KCNIP1 and KCND2. May be involved in increased cytokine secretion associated with cellular senescence.

    Aliases: MMDS3 antibody, MVti1 antibody, SNARE Vti1a beta protein antibody, Vesicle transport through interaction with t-SNAREs homolog 1A antibody, Vesicle transport through interaction with tSNAREs homolog 1A (yeast) antibody, Vesicle transport v-SNARE protein Vti1-like 2 antibody, Vti1 rp2 antibody, Vti1-rp2 antibody, Vti1a antibody, VTI1A vesicle transport through interaction with t-SNAREs 1A antibody, VTI1A_HUMAN antibody, VTI1RP2 antibody

    UniProt
    Q96AJ9
Sie sind hier: